CMOTEC B — Scandinavian ChemoTech AB Balance Sheet
0.000.00%
- SEK87.07m
- SEK86.56m
- SEK6.57m
Annual balance sheet for Scandinavian ChemoTech AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | — | — | — | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 1.49 | 8.68 | 5.85 | 0.923 | 0.949 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.09 | 1.53 | 1.67 | 1.16 | 1.89 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 4.13 | 13.4 | 11.8 | 7.2 | 7.77 |
| Net Property, Plant And Equipment | 0.062 | 0.073 | 0.035 | 0.012 | 0.004 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 16 | 25.8 | 21.7 | 14.9 | 13.4 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.7 | 1.89 | 7.71 | 3.84 | 7.4 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 6.75 | 1.89 | 7.71 | 3.84 | 7.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 9.24 | 23.9 | 14 | 11 | 5.98 |
| Total Liabilities & Shareholders' Equity | 16 | 25.8 | 21.7 | 14.9 | 13.4 |
| Total Common Shares Outstanding |